Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

HUMAW

Humacyte (HUMAW)

Humacyte Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:HUMAW

1

Data	Hora	Fonte	Título	Código	Companhia
23/01/2025	18:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMAW	Humacyte Inc
20/12/2024	18:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMAW	Humacyte Inc
20/11/2024	21:10	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:HUMAW	Humacyte Inc
20/11/2024	18:12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HUMAW	Humacyte Inc
14/11/2024	10:17	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:HUMAW	Humacyte Inc
08/11/2024	18:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HUMAW	Humacyte Inc
08/11/2024	16:17	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:HUMAW	Humacyte Inc
17/06/2024	17:10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:HUMAW	Humacyte Inc
04/06/2024	20:00	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:HUMAW	Humacyte Inc